{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T04:08:01Z","timestamp":1688270881473},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,7,1]]},"DOI":"10.2169\/internalmedicine.0209-22","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T22:09:56Z","timestamp":1668550196000},"page":"2009-2012","source":"Crossref","is-referenced-by-count":1,"title":["Glucocorticoid in Combination with a TNF-\u03b1 Inhibitor: Treatment of Deep Vein Thrombosis in a Patient with Beh\u00e7et's Disease"],"prefix":"10.2169","volume":"62","author":[{"given":"Mitsumasa","family":"Okano","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Ichise","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sentaro","family":"Kusuhara","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokazu","family":"Muramae","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Otsui","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bettiol A, Prisco D, Emmi G. Beh\u00e7et: the syndrome. Rheumatology (Oxford) 59: iii101-iii107, 2020.","DOI":"10.1093\/rheumatology\/kez626"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Seyahi E. Beh\u00e7et&apos;s disease: how to diagnose and treat vascular involvement. Best Pract Res Clin Rheumatol 30: 279-295, 2016.","DOI":"10.1016\/j.berh.2016.08.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Beh\u00e7et&apos;s syndrome. Ann Rheum Dis 77: 808-818, 2018.","DOI":"10.1136\/annrheumdis-2018-213225"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol 56: 1-7, 2010.","DOI":"10.1016\/j.jacc.2010.01.057"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Emmi G, Silvestri E, Squatrito D, et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J 13: 15, 2015.","DOI":"10.1186\/s12959-015-0047-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mehdipoor G, Davatchi F, Ghoreishian H, Arjmand Shabestari A. Imaging manifestations of Behcet&apos;s disease: key considerations and major features. Eur J Radiol 98: 214-225, 2018.","DOI":"10.1016\/j.ejrad.2017.11.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Alibaz-Oner F, Ergelen R, Mutis A, et al. Venous vessel wall thickness in lower extremity is increased in male patients with Behcet&apos;s disease. Clin Rheumatol 38: 1447-1451, 2019.","DOI":"10.1007\/s10067-019-04470-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Becatti M, Emmi G, Silvestri E, et al. Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Beh\u00e7et disease. Circulation 133: 302-311, 2016.","DOI":"10.1161\/CIRCULATIONAHA.115.017738"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Becatti M, Emmi G, Bettiol A, et al. Beh\u00e7et&apos;s syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects. Clin Exp Immunol 195: 322-333, 2019.","DOI":"10.1111\/cei.13243"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS. Treatment of venous thrombosis associated with Behcet&apos;s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27: 201-205, 2008.","DOI":"10.1007\/s10067-007-0685-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Seyahi E, Cakmak OS, Tutar B, et al. Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behcet syndrome: an observational study. Med (Baltim) 94: e1899, 2015.","DOI":"10.1097\/MD.0000000000001899"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Desbois AC, Wechsler B, Resche-Rigon M, et al. Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et&apos;s disease. Arthritis Rheum 64: 2753-2760, 2012.","DOI":"10.1002\/art.34450"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vautier M, Gallien Y, Emmi G, et al. Direct oral anticoagulant for venous thrombosis in Beh\u00e7et&apos;s syndrome. Autoimmun Rev 20: 102783, 2021.","DOI":"10.1016\/j.autrev.2021.102783"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ouchi K, Narui R, Sakuma T, Ojiri H. Serious complication of anticoagulation in vessel thrombosis-associated Beh\u00e7et disease. Intern Med 59: 1615-1620, 2020.","DOI":"10.2169\/internalmedicine.4109-19"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/13\/62_0209-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T03:26:21Z","timestamp":1688181981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/13\/62_0209-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0209-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"article-number":"0209-22"}}